Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alacramyn NAMO for Scorpion Envenomation in Children
NCT01336660Phase 3Completed
- Sponsor
- Instituto Bioclon S.A. de C.V.
- Start
- Jul 2018
- Primary completion
- Nov 2018
- Modality
- Antibody Fragments
- Countries
- 1
01
Overview
A Phase 3 trial of centruroides (scorpion) immune F(ab')₂ (equine) in scorpion envenomation, sponsored by Instituto Bioclon S.A. de C.V.. Started Jul 2018; status: completed.
02
Drugs
centruroides (scorpion) immune F(ab')₂ (equine)
03
Conditions
scorpion envenomation
Beyond the preview
Go deeper on NCT01336660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01336660.